التفاصيل البيبلوغرافية
العنوان:
Increasing the purity, potency and specificity of ebv-specific T cells to improve the treatment of EBV-positive lymphoma
المؤلفون:
Natalia Lapteva , Minhtran C. Ngo , Cliona M. Rooney , Catherine M. Bollard , Rayne H. Rouce , Serena K. Perna , Carlos A. Ramos , Ann M. Leen , Sandhya Sharma , Adrian P. Gee , Birju Mehta , Helen E. Heslop , Vicky Torrano
المصدر:
Journal for Immunotherapy of Cancer
بيانات النشر:
BioMed Central, 2015.
سنة النشر:
2015
مصطلحات موضوعية:
Pharmacology , Cancer Research , business.industry , viruses , Immunology , Bioinformatics , medicine.disease , Genome , Virology , Virus , Lymphoma , Oncology , immune system diseases , hemic and lymphatic diseases , Poster Presentation , Viral latency , EBV Positive , medicine , Molecular Medicine , Immunology and Allergy , Potency , business
الوصف:
Meeting abstracts Up to ~40 % of Hodgkin and non-Hodgkin lymphomas carry the Epstein-Barr virus (EBV) genome and express type 2 viral latency proteins (T2LPs) EBNA-1, LMP-1, LMP-2 and BARF-1. EBV specific T cells (EBVSTs) can be generated from the blood of EBV+ individuals, but are usually
اللغة:
English
تدمد:
2051-1426
URL الوصول:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27367a5063d170d3f93a92af91e91389 http://europepmc.org/articles/PMC4646123
حقوق:
OPEN
رقم الأكسشن:
edsair.doi.dedup.....27367a5063d170d3f93a92af91e91389
قاعدة البيانات:
OpenAIRE
Find this article in full text from Springer Verlag.